ES2056025A1 - Nuevos derivados de indol. - Google Patents

Nuevos derivados de indol.

Info

Publication number
ES2056025A1
ES2056025A1 ES09201993A ES9201993A ES2056025A1 ES 2056025 A1 ES2056025 A1 ES 2056025A1 ES 09201993 A ES09201993 A ES 09201993A ES 9201993 A ES9201993 A ES 9201993A ES 2056025 A1 ES2056025 A1 ES 2056025A1
Authority
ES
Spain
Prior art keywords
alkyl group
indole derivatives
new indole
image
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09201993A
Other languages
English (en)
Other versions
ES2056025B1 (es
Inventor
Noguera Ferran Pujol
Crespo M Isabel Crespo
Duran Carles Puig
Forner Dolors Fernandez
Mauri Jacinto Moagues
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Almirall SA
Original Assignee
Laboratorios Almirall SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Almirall SA filed Critical Laboratorios Almirall SA
Priority to ES9201993A priority Critical patent/ES2056025B1/es
Publication of ES2056025A1 publication Critical patent/ES2056025A1/es
Application granted granted Critical
Publication of ES2056025B1 publication Critical patent/ES2056025B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

NUEVOS DERIVADOS DE INDOL DE FORMULA: FORMULA DONDE RBS1 SC Y RBS2 SC CADA UNO REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO, Z REPRESENTA UN ANILLO SELECCIONADO ENTRE: FORMULA DONDE N REPRESENTA 4, 5 O 6; RBS3 SC REPRESENTA HIDROGENO O UN GRUPO ALQUILO, RBS4 SC REPRESENTA UN GRUPO ALQUILO, METOXI, BENCIL O RBS5 SCNHCO, SIENDO RBS5 SC UN GRUPO ALQUILO; Y RBS6 SC REPRESENTA UN GRUPO ALQUILO; Y SALES FARMACEUTICAMENTE ACEPTABLES DE LOS MISMOS, ASI COMO SU PROCEDIMIENTO DE PREPARACION. ESTOS COMPUESTOS SON UTILES PARA EL TRATAMIENTO O PREVENCION DE LA MIGRAÑA, TRANSTORNOS DEL EQUILIBRIO, DEPRESION Y ANSIEDAD.
ES9201993A 1992-10-08 1992-10-08 Nuevos derivados de indol. Expired - Fee Related ES2056025B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9201993A ES2056025B1 (es) 1992-10-08 1992-10-08 Nuevos derivados de indol.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9201993A ES2056025B1 (es) 1992-10-08 1992-10-08 Nuevos derivados de indol.

Publications (2)

Publication Number Publication Date
ES2056025A1 true ES2056025A1 (es) 1994-09-16
ES2056025B1 ES2056025B1 (es) 1995-05-01

Family

ID=8278343

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9201993A Expired - Fee Related ES2056025B1 (es) 1992-10-08 1992-10-08 Nuevos derivados de indol.

Country Status (1)

Country Link
ES (1) ES2056025B1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2505715T1 (es) 2013-02-06 2014-10-10 Galenicum Health S.L. Composición farmacéutica que comprende almotriptán malato que tiene una distribución y potencia uniforme

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082175A (en) * 1980-08-12 1982-03-03 Glaxo Group Ltd Heterocyclic compounds
GB2124210A (en) * 1982-06-07 1984-02-15 Glaxo Group Ltd Indoles
GB2168347A (en) * 1984-12-13 1986-06-18 Glaxo Group Ltd Indoles
EP0303506A2 (en) * 1987-08-13 1989-02-15 Glaxo Group Limited Indole derivatives
WO1991018897A1 (en) * 1990-06-07 1991-12-12 The Wellcome Foundation Limited Therapeutic heterocyclic compounds
ES2033578A1 (es) * 1991-06-06 1993-03-16 Inke Sa Procedimiento para la obtencion de 3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2082175A (en) * 1980-08-12 1982-03-03 Glaxo Group Ltd Heterocyclic compounds
GB2124210A (en) * 1982-06-07 1984-02-15 Glaxo Group Ltd Indoles
GB2168347A (en) * 1984-12-13 1986-06-18 Glaxo Group Ltd Indoles
EP0303506A2 (en) * 1987-08-13 1989-02-15 Glaxo Group Limited Indole derivatives
WO1991018897A1 (en) * 1990-06-07 1991-12-12 The Wellcome Foundation Limited Therapeutic heterocyclic compounds
ES2033578A1 (es) * 1991-06-06 1993-03-16 Inke Sa Procedimiento para la obtencion de 3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida.

Also Published As

Publication number Publication date
ES2056025B1 (es) 1995-05-01

Similar Documents

Publication Publication Date Title
TW229140B (es)
MX9801410A (es) Nuevas n-aminoalquilfluorencarboxamidas; una nueva clase de ligandos especificos del subtipo del receptor de la dopamina.
ES8707223A1 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofen.
TW341565B (en) Indole derivatives processes and intermediates for their preparation and pharmaceutical compositions containing them
MY113266A (en) New indol derivatives derivatives with high affinity 5-ht1a receptor.
DE69227088D1 (de) Verwendung von 1-(aminoalkyl)-3-Quinoxalin-2-on Derivaten zur Herstellung von neuroprotektiven Mitteln
TW347386B (en) N-substituted β-aryl- and β-heteroaryl-α-cyanoacrylamide derivatives
GB9306886D0 (en) Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
ES455741A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1,3-bencenodimetanol.
GB9306899D0 (en) Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
UA43338C2 (uk) Похідні бензолу
ES2056025A1 (es) Nuevos derivados de indol.
ES2128960A1 (es) Derivados de fluorofenil-triazinas y pirimidinas compuestos farmacologicamente activos en el sistema nervioso central.
ES2009283A6 (es) Procedimiento para preparar nuevos aminoacilatos de glicerol-acetal.

Legal Events

Date Code Title Description
PC2A Transfer of patent
PC2A Transfer of patent
SPCF Request for supplementary protection certificate filed

Free format text: ALMOTRIPTAN (ALMOGRAN)

Spc suppl protection certif: C200000011

Filing date: 20000503

SPCG Supplementary protection certificate granted

Free format text: ALMOTRIPTAN (ALMOGRAN).

Spc suppl protection certif: C200000011

Filing date: 20000503

Expiry date: 20141223

Effective date: 20031106

Free format text: ALMOTRIPTAN (ALMOGRAN)

Spc suppl protection certif: C200000011

Filing date: 20000503

Expiry date: 20141223

Effective date: 20031106

FD2A Announcement of lapse in spain

Effective date: 20141120